Company intelligence / Profile preview

Biovico

Gdynia, Pomeranian Voivodeship, Polandbiovico.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Biovico has launched several medical devices and pharmaceutical products in orthopedics (notably viscosupplements based on hyaluronic acid for osteoarthritis) and neurology. Their products are CE-marked and manufactured under GMP standards. Clinical results highlight accelerated pain relief with sustained effects for their viscosupplementation therapies.

Therapeutic areas: RheumatologyNeurology
Modalities: BiologicBlood-based injectable therapyHyaluronic acid-based therapyMedical device
Industry: Therapeutic Medical Devices

Partnerships

Not specifically disclosed in public sources.

Beyond the preview

Go deeper on Biovico.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biovico.

Explore the full profile